WBSCR16 Antibody

What is WBSCR16 and why is it important in research?

WBSCR16 (Williams-Beuren Syndrome Chromosome Region 16), also known as RCC1L, is a protein that plays a critical role in mitochondrial function. The gene encoding WBSCR16 is located in a large deletion region associated with Williams-Beuren syndrome (WBS), a neurodevelopmental disorder . Research has demonstrated that WBSCR16 is essential for mitochondrial 16S rRNA processing and mitochondrial ribosome assembly, making it a key factor in mitochondrial translation and respiratory chain function . Structurally, WBSCR16 adopts a seven-bladed β-propeller fold characteristic of RCC1-like proteins, though its function appears distinct from other members of this protein superfamily .

The significance of WBSCR16 in research stems from its crucial role in:

• Regulation of mitochondrial ribosome assembly

• Processing of mitochondrial 16S rRNA

• Maintenance of mitochondrial morphology and function

• Metabolic flexibility determination

These functions make WBSCR16 antibodies valuable tools for investigating mitochondrial biology, energy metabolism, and potentially the pathophysiology of Williams-Beuren syndrome.

What are the primary applications for WBSCR16 antibodies in basic research?

WBSCR16 antibodies are employed in several fundamental research applications:

Methodologically, these applications allow researchers to:

• Quantify WBSCR16 expression in different cell types or tissues

• Investigate protein-protein interactions involving WBSCR16

• Examine subcellular localization, particularly within mitochondrial compartments

• Study the effects of genetic manipulations (knockout/overexpression) on WBSCR16 levels

How do I select the appropriate WBSCR16 antibody for my specific research needs?

Selection of the optimal WBSCR16 antibody should be based on several criteria:

• Target specificity: Select antibodies targeting specific regions of interest within WBSCR16. Available options include:

  • N-terminal-specific antibodies (e.g., ABIN2791205 targeting amino acids in the N-terminal region)

  • Mid-region antibodies (e.g., targeting AA 115-164)

  • Full-length antibodies (e.g., targeting AA 1-464)

• Species reactivity: Verify cross-reactivity with your experimental model species. Some WBSCR16 antibodies show reactivity with:

  • Human samples (most common)

  • Mouse and rat models

  • Other mammals (cow, dog, guinea pig, etc.)

• Application compatibility: Ensure the antibody has been validated for your specific application (WB, ELISA, IHC, etc.)

• Clonality consideration:

  • Polyclonal antibodies offer broader epitope recognition

  • Monoclonal antibodies provide higher specificity for a single epitope

• Validation data: Review published literature and validation data from suppliers to confirm specificity and performance in your planned applications

What are the recommended protocols for optimizing WBSCR16 antibody use in Western blotting?

For optimal Western blot results with WBSCR16 antibodies, consider the following methodological approach:

• Sample preparation:

  • For whole-cell lysates: Use RIPA buffer with protease inhibitors

  • For mitochondrial fractions: Employ differential centrifugation techniques to isolate intact mitochondria before lysis

• Protein loading and detection:

  • Load 20-30 μg of total protein per lane

  • WBSCR16 appears at approximately 50 kDa molecular weight

• Dilution optimization:

  • Start with manufacturer's recommended dilution (typically 1:500-1:1000 for WBSCR16 antibodies)

  • Perform a dilution series if signal-to-noise ratio is suboptimal

• Controls:

  • Positive controls: HeLa or Jurkat cell lysates show detectable WBSCR16 expression

  • Negative controls: WBSCR16 knockout cell lysates can serve as specificity controls

• Blocking optimization:

  • Use 5% non-fat dry milk or BSA in TBST

  • Block for 1 hour at room temperature

• Secondary antibody selection:

  • Use species-appropriate HRP-conjugated secondary antibodies

  • Typical dilution range: 1:5000-1:10000

How can WBSCR16 antibodies be used to investigate mitochondrial ribosome assembly defects?

WBSCR16 antibodies can be employed in several sophisticated approaches to study mitochondrial ribosome assembly:

• Ribosomal fractionation analysis:

  • Utilize sucrose gradient fractionation (10%-30%) to separate mitochondrial ribosomal subunits

  • Employ WBSCR16 antibodies in Western blot analysis of fractions to track its association with ribosomal components

  • Use antibodies against large ribosomal subunits (MRPL37, MRPL12) and small ribosomal subunits (MRPS35, MRPS16) as comparative markers

• Co-immunoprecipitation studies:

  • Use WBSCR16 antibodies to pull down associated proteins

  • Identify interactions with mitochondrial ribosomal proteins or processing factors like MRPP3

  • Analyze changes in these interactions under different conditions (knockout vs. wild-type)

• Proximity labeling approaches:

  • Couple WBSCR16 antibodies with proximity labeling techniques (BioID, APEX)

  • Map the proximal interactome of WBSCR16 within the mitochondrial compartment

Research has demonstrated that WBSCR16 knockout leads to disassembly of large ribosomal subunits in mitochondria and inhibition of translational activities of mitochondria-encoded proteins . These techniques can help elucidate the mechanistic details of this process.

What methodologies are recommended for investigating WBSCR16's role in 16S rRNA processing?

To study WBSCR16's involvement in 16S rRNA processing, researchers should consider these methodological approaches:

• RNA immunoprecipitation (RIP) with WBSCR16 antibodies:

  • Use cross-linking to preserve RNA-protein interactions

  • Immunoprecipitate with WBSCR16 antibodies

  • Analyze bound RNAs by qRT-PCR or RNA sequencing

  • Research has shown that 16S rRNA is the most highly enriched transcript associated with WBSCR16 across the entire mitochondrial transcriptome

• Northern blot analysis:

  • Use specific probes for 16S rRNA, 12S rRNA, and unprocessed precursors

  • Compare patterns between wild-type and WBSCR16-deficient samples

  • Studies have shown marked reduction in mature 16S rRNA levels in WBSCR16 knockout tissues, while 12S rRNA levels remained relatively unchanged

• Analysis of unprocessed precursor accumulation:

  • Design qRT-PCR primers spanning junction regions (e.g., 16S rRNA-tRNALeu)

  • Quantify unprocessed transcripts in WBSCR16 knockout vs. wild-type tissues

  • Research has demonstrated significant upregulation of unprocessed transcripts containing regions from 12S rRNA to mt-tRNALeu in WBSCR16 knockout samples

• Triple-complex analysis:

  • Use sequential immunoprecipitation to study the 16S rRNA:WBSCR16:MRPP3 tripartite complexes

  • This approach can demonstrate how WBSCR16 facilitates processing of 16S rRNA through interaction with the RNase P complex component MRPP3

How do WBSCR16 antibodies help elucidate the protein's role in mitochondrial fusion?

WBSCR16 antibodies provide valuable tools for investigating the protein's role in mitochondrial dynamics through these methodologies:

• Subcellular localization studies:

  • Use immunofluorescence with WBSCR16 antibodies to determine precise mitochondrial localization

  • Research has shown that WBSCR16 is primarily associated with the outer face of the inner mitochondrial membrane

  • Co-staining with OPA1 can reveal co-localization patterns

• Protein-protein interaction studies with fusion machinery:

  • Employ co-immunoprecipitation with WBSCR16 antibodies to pull down interacting proteins

  • Western blot for mitochondrial fusion proteins (particularly OPA1)

  • Research has demonstrated that WBSCR16 acts as a Guanine Nucleotide Exchange Factor (GEF) for OPA1, but not for MFN1 or MFN2

• Mitochondrial morphology assessment:

  • Use WBSCR16 antibodies in knockdown/knockout validation

  • Correlate WBSCR16 levels with changes in mitochondrial morphology

  • Studies have shown that CRISPR/Cas-9 knockout of WBSCR16 results in mitochondrial fragmentation

• Mitochondrial membrane subfractionation:

  • Use digitonin treatment to strip away outer membranes

  • Perform sequential immunoprecipitation with WBSCR16 antibodies before and after mitoplast lysis

  • This approach has revealed that the majority of WBSCR16 is located on the inner membrane outer face

What techniques using WBSCR16 antibodies can reveal its role in metabolic flexibility?

To investigate WBSCR16's contribution to metabolic flexibility, researchers can employ these antibody-based methodologies:

• Correlation of WBSCR16 expression with metabolic parameters:

  • Use Western blotting with WBSCR16 antibodies to quantify protein levels

  • Correlate with measurements of oxygen consumption, substrate utilization, and metabolic switching

  • Research has shown higher oxygen consumption in WBSCR16 knockout adipocytes

• Analysis of respiratory chain complex assembly:

  • Use WBSCR16 antibodies to validate knockout models

  • Perform subsequent analysis of respiratory chain complexes

  • Studies have revealed significant decreases in most mtDNA-encoded proteins in WBSCR16-deficient tissues

• Mitochondrial membrane potential assessment:

  • Validate WBSCR16 manipulation using antibodies

  • Correlate with functional measurements of membrane potential

  • Research has shown better mitochondrial membrane potential in WBSCR16 knockout cells despite the loss of mitochondrial cristae

• Substrate utilization experiments:

  • Use WBSCR16 antibodies to confirm protein levels in experimental models

  • Measure glucose versus fatty acid utilization in cells with different WBSCR16 expression levels

  • This approach can reveal how WBSCR16 affects metabolic substrate preference

What are common challenges when using WBSCR16 antibodies and how can they be addressed?

Researchers frequently encounter these challenges when working with WBSCR16 antibodies:

• Non-specific binding and background:

  • Solution: Optimize blocking conditions (try 5% BSA instead of milk for phosphorylation studies)

  • Solution: Increase washing duration/frequency and ensure appropriate detergent concentration in wash buffers

  • Solution: Test multiple antibody concentrations to find optimal signal-to-noise ratio

• Poor signal intensity in Western blots:

  • Solution: Ensure adequate protein loading (30-50 μg for total cell lysates)

  • Solution: Consider mitochondrial enrichment protocols to concentrate WBSCR16

  • Solution: Use enhanced chemiluminescence (ECL) substrates with higher sensitivity

  • Solution: Increase antibody incubation time (overnight at 4°C)

• Inconsistent results between experiments:

  • Solution: Standardize lysate preparation methods

  • Solution: Include positive controls (HeLa or Jurkat cells) in each experiment

  • Solution: Prepare larger batches of antibody dilutions to use across multiple experiments

• Difficulty detecting mitochondrial localization:

  • Solution: Use mitochondrial isolation protocols prior to Western blotting

  • Solution: For immunofluorescence, perform antigen retrieval optimization

  • Solution: Consider subcellular fractionation to enrich mitochondrial components

How can I validate the specificity of WBSCR16 antibodies in my experimental system?

To ensure antibody specificity, implement these validation strategies:

• Genetic approaches:

  • Generate WBSCR16 knockout cells using CRISPR/Cas9 as negative controls

  • Create WBSCR16 overexpression systems as positive controls

  • Compare antibody reactivity across these systems

• Peptide competition assays:

  • Pre-incubate the antibody with excess immunizing peptide

  • Observe elimination of specific signal in Western blot or immunostaining

  • Use unrelated peptides as negative controls

• Multiple antibody validation:

  • Test antibodies targeting different epitopes of WBSCR16

  • Compare reactivity patterns across different applications

  • Consistent results across different antibodies suggest specificity

• Correlation with mRNA expression:

  • Measure WBSCR16 mRNA levels using qRT-PCR

  • Compare with protein levels detected by the antibody

  • Consistent correlation supports antibody specificity

• Mass spectrometry validation:

  • Perform immunoprecipitation with WBSCR16 antibody

  • Analyze pulled-down proteins by mass spectrometry

  • Confirmation of WBSCR16 peptides supports antibody specificity

How might WBSCR16 antibodies contribute to understanding Williams-Beuren syndrome pathophysiology?

While the direct connection between WBSCR16 and Williams-Beuren syndrome (WBS) pathophysiology remains under investigation, WBSCR16 antibodies could contribute to this research through:

• Expression pattern analysis in neuronal tissues:

  • Compare WBSCR16 expression in brain regions affected in WBS

  • Correlate expression with neurological and behavioral phenotypes

  • Investigate developmental regulation of WBSCR16 in neural tissues

• Mitochondrial function assessment in WBS models:

  • Use WBSCR16 antibodies to measure protein levels in WBS patient-derived cells

  • Correlate with mitochondrial function parameters

  • Investigate how WBSCR16 haploinsufficiency affects mitochondrial translation and function

• Interaction studies with other WBS region proteins:

  • Employ co-immunoprecipitation with WBSCR16 antibodies

  • Identify potential interactions with other proteins encoded in the WBS deletion region

  • Explore functional consequences of these interactions

• Cellular energy metabolism in WBS:

  • Given WBSCR16's role in metabolic flexibility , investigate how its deficiency might contribute to metabolic aspects of WBS

  • Use WBSCR16 antibodies to validate model systems for these studies

What innovative experimental approaches could advance our understanding of WBSCR16's molecular functions?

Cutting-edge methodologies incorporating WBSCR16 antibodies could include:

• Proximity-dependent biotin labeling (BioID or TurboID):

  • Generate WBSCR16-BioID fusion proteins

  • Map the proximal interactome of WBSCR16 within mitochondria

  • Validate interactions using co-immunoprecipitation with WBSCR16 antibodies

• Live-cell imaging with nanobody derivatives:

  • Develop nanobodies derived from WBSCR16 antibodies

  • Use for live-cell imaging of WBSCR16 dynamics

  • Correlate with mitochondrial fusion/fission events

• Cryo-electron microscopy studies:

  • Use WBSCR16 antibodies to purify native complexes

  • Determine high-resolution structures of WBSCR16 in complex with binding partners

  • Correlate structural features with functional data

• Patient-derived cellular models:

  • Generate induced pluripotent stem cells (iPSCs) from WBS patients

  • Differentiate into relevant cell types (neurons, adipocytes)

  • Use WBSCR16 antibodies to assess protein levels and localization

• Synthetic biology approaches:

  • Design modified versions of WBSCR16 with domain deletions or mutations

  • Express in WBSCR16-knockout backgrounds

  • Use WBSCR16 antibodies to validate expression and study functional consequences